By Dave Andrusko
It is unfortunately not surprising that pro-abortionists in Australia are aggressively touting the market for their new ‘service’–chemical abortions without a woman ever meeting an abortionist or pharmacist face-to-face.
And, according to an enthusiastic Amy Corderoy, health editor for the Sydney Morning Herald, demand for the new service from the Tabbot Foundation is overwhelming.
Who exactly the Tabbot Foundation is remains a mystery. As Steve Weatherb observed, the name mocks recently-ousted, pro-life Prime Minister Tony Abbott “who as health minister a decade ago fought in vain against Mifepristone’s [RU-486’s] introduction.
“[In September] Abbott was ousted from the prime ministry by the Liberal caucus”
Here’s how the new system is intended to work:
The woman would call the service’s toll-free number …and would be referred to local, preferably bulk-billing, providers to test her blood and give her an ultrasound to ensure the pregnancy was suitable. The doctor would get the results to use in a phone consultation.
In states such as NSW [New South Wales] where a psychological assessment is required, this would also be done over the phone. If the treatment is approved, the women is posted [sent by mail] a package including the medications mifepristone and misoprostol (commonly known as RU486), prophylactic antibiotics, painkillers and anti-nausea drugs, all at a cost of $250.
Tabbot, which was established to provide Australia-wide phone service abortions, charges a flat fee of A$250 (about $175 in U.S. dollars) for women with a Medicare card and A$600 (about U.S. $420) for those without. Everyone who lives in Australia, excluding Norfolk Island, is eligible for a Medicare card, according to the Department of Human Services
In a follow up story posted Friday, Corderoy channeled Reproductive Choice Australia co-president Jenny Ejlak who
said the number of calls to the Tabbot Foundation “should be a wake-up call” for governments, which had failed to properly plan to provide abortion services and also to ensure proper strategies were put in place to prevent unwanted pregnancies in the first place.
Added Tabbot Foundation medical director Paul Hyland the demand is supposedly so high
Until further notice, in cases where we cannot provide a service to a woman within 48 hours, they will be directed to their closest medical provider, where pregnancy termination services are known to exist.
Last month NRLC Director of Education Dr. Randall K. O’Bannon wrote about the 15th anniversary of the introduction of RU-486 into the United States which took place September 28.
The RU-486 chemical abortion is actually a potent two-drug technique, one to kill the baby, the other to induce contractions to expel the dead baby. But it also dangerous to the babies’ mothers.
An April 2011 FDA report requested by a U.S. Senator found more that 2,200 “adverse events” associated with use of the mifepristone/misoprostol combo with 14 known deaths in the U.S. and at least five more in other countries. Deadly infections killed eight of the 14 in the U.S.
And that, of course, was over four years ago.
As part of an otherwise celebratory article that appeared online at the Australian Broadcasting network, there was this cautionary note from Obstetrician and former Australian Medical Association president Dr. Andrew Pesce:
For women who would prefer to avoid a surgical operation or who live in parts of Australia where it’s not so easy to organise, this is obviously an addition to an option which you know helps them out.
There is however a need for this type of service to be well integrated with mainstream services as well. About 10-20 percent women who have a medical abortion using mifepristone, or RU486, will not completely miscarry, and require a subsequent surgical procedure.
And the last thing I want to see is women who’ve taken this pill end up with pain and bleeding and end up in an ED department at a busy hospital on a Saturday night, you know, needing to take several hours to get through a busy system which isn’t part of an integrated care plan.
Over the next few years, thousands of “adverse event reports” flooded the FDA, with news of hundreds of women hemorrhaging, dealing with serious infections, suffering from ruptured ectopic pregnancies. More than a dozen women died, and there were more deaths associated with use of the drug outside the United States.
And that was of 2011!